Treatment of Lymphangiomas with OK-432 (Picibanil)
Treatment of Lymphangiomas with OK-432 (Picibanil)
About this item
Full title
Author / Creator
Publisher
Heidelberg: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Heidelberg: Springer
Subjects
More information
Scope and Contents
Contents
To determine the efficacy of OK-432 sclerotherapy in the treatment of lymphangiomas.
The treatment was begun for 14 patients with lymphangioma. The age range of the patients at the time of the first injection was from 10 months to 42 years. Eleven of the lesions involved the head and neck region, two the thorax and one was localized in the extre...
Alternative Titles
Full title
Treatment of Lymphangiomas with OK-432 (Picibanil)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_osti_scitechconnect_21088421
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_21088421
Other Identifiers
ISSN
0174-1551
E-ISSN
1432-086X
DOI
10.1007/s00270-002-1980-3
